P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS FOR JUVENILE MYELOMONOCYTIC LEUKEMIA IN EX VIVO DRUG SENSITIVITY ASSAYS

por Stieglitz, Elliot, Gu, Christine, Dhar, Anukriti, Huebner, Juwita, Ali, Kamran, Lacher, Markus
Publicado 2023

SFRP-4 abrogates Wnt-3a-induced β-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation

por Constantinou, Thecla, Baumann, Fabrizio, Lacher, Markus D, Saurer, Susanne, Friis, Robert, Dharmarajan, Arun
Publicado 2008

ZEB1 limits adenoviral infectability by transcriptionally repressing the Coxsackie virus and Adenovirus Receptor

por Lacher, Markus D, Shiina, Marisa, Chang, Peter, Keller, Debora, Tiirikainen, Maarit I, Korn, W Michael
Publicado 2011

Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay

por Stieglitz, Elliot, Gu, Christine J., Richardson, Michelle, Kita, Ryosuke, Santaguida, Marianne T., Ali, Kamran A., Strachan, Debbie C., Dhar, Anukriti, Yam, George, Anderson, Wade, Anderson, Erica, Hübner, Juwita, Tasian, Sarah K., Loh, Mignon L., Lacher, Markus D.
Publicado 2023

SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4(+) T Lymphocytes

por Lacher, Markus D., Bauer, Gerhard, Fury, Brian, Graeve, Sanne, Fledderman, Emily L., Petrie, Tye D., Coleal-Bergum, Dane P., Hackett, Tia, Perotti, Nicholas H., Kong, Ying Y., Kwok, William W., Wagner, Joseph P., Wiseman, Charles L., Williams, William V.
Publicado 2018